Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Eledon Pharmaceuticals ( (ELDN) ) has issued an update.
Eledon Pharmaceuticals announced an amendment to the employment agreement of its CEO, David-Alexandre Gros, adjusting the market value cap for his performance bonus. The CEO’s bonus structure has been altered, allowing for a maximum bonus of $15 million if the company’s market value reaches $1.5 billion, with linear interpolation determining payouts between set thresholds.
More about Eledon Pharmaceuticals
YTD Price Performance: 134.44%
Average Trading Volume: 491,893
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $252.1M
For detailed information about ELDN stock, go to TipRanks’ Stock Analysis page.
